{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:35:12Z","timestamp":1773855312736,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T00:00:00Z","timestamp":1363564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059346","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T20:59:07Z","timestamp":1363640347000},"page":"e59346","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy"],"prefix":"10.1371","volume":"8","author":[{"given":"Summer L.","family":"Day","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Odem-Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishorchandra N.","family":"Mandaliya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnet N.","family":"Masese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Nina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Scott","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,18]]},"reference":[{"key":"ref1","first-page":"25","article-title":"Viral hepatitis and HIV in Africa","volume":"9","author":"AA Modi","year":"2007","journal-title":"AIDS Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1473-3099(07)70135-4","article-title":"Clinical implications of HIV and hepatitis B co-infection in Asia and Africa","volume":"7","author":"CJ Hoffmann","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"D Levanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/QAD.0b013e3282f8b46f","article-title":"Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel","volume":"22","author":"V Soriano","year":"2008","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2005.11.015","article-title":"Natural history of chronic hepatitis B in co-infected patients","volume":"44","author":"M Puoti","year":"2006","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/593104","article-title":"Hepatitis B Virus infection and response to Antiretroviral Therapy (ART) in a South African ART Program","volume":"47","author":"CJ Hoffmann","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1016\/j.ijid.2010.06.013","article-title":"Hepatitis B\/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis","volume":"14","author":"RE Barth","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COH.0b013e3283339b41","article-title":"Improving first-line antiretroviral therapy in resource-limited settings","volume":"5","author":"N Ford","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.510300525","article-title":"Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients","volume":"30","author":"Y Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"ref10","first-page":"1","article-title":"Global Report: UNAIDS report on the global AIDS epidemic","volume":"10","year":"2010","journal-title":"Accessed 2012 Sep"},{"key":"ref11","unstructured":"World Health Organization (WHO) (2010 Revision) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/adult\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/adult\/en\/index.html<\/ext-link>. Accessed 2012 May 10."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3851\/IMP1911","article-title":"Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon","volume":"17","author":"C Kouanfack","year":"2012","journal-title":"Antivir Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/QAD.0b013e328349bbf3","article-title":"Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV\/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa","volume":"25","author":"GV Matthews","year":"2011","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/JCM.02231-09","article-title":"Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana","volume":"48","author":"AM Geretti","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/1756-0500-4-561","article-title":"Emergence of HBV resistance to lamivudine (3TC) in HIV\/HBV co-infected patients in The Gambia, West Africa","volume":"4","author":"B Stewart","year":"2011","journal-title":"BMC Res Notes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1111\/j.1365-2893.2011.01466.x","article-title":"HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine, and nevirapine in Kenya","volume":"18","author":"NH Kim","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/656790","article-title":"Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment","volume":"202","author":"SM Graham","year":"2010","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/01.aids.0000247119.12327.e6","article-title":"HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers","volume":"20","author":"RS McClelland","year":"2006","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/00002030-200310170-00007","article-title":"Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996\u20132001","volume":"17","author":"W Law","year":"2003","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/01.aids.0000218550.85081.59","article-title":"Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy","volume":"20","author":"GV Matthews","year":"2006","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/QAI.0b013e3180314b46","article-title":"Hepatitis B virus genotypes and lamivudine resistance mutations in HIV\/hepatitis B virus-coinfected patients","volume":"44","author":"B Ramos","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2893.2005.00624.x","article-title":"Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy","volume":"12","author":"A Kramvis","year":"2005","journal-title":"J Viral Hepat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1478-3231.2005.01177.x","article-title":"Therapeutic Implications of hepatitis b virus genotypes","volume":"25","author":"C Liu","year":"2005","journal-title":"Liver International"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jmv.2087","article-title":"Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy","volume":"65","author":"B Zollner","year":"2001","journal-title":"J Med Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/339959","article-title":"Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment","volume":"34","author":"B Zollner","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0168-8278(01)00283-5","article-title":"Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?","volume":"36","author":"M Buti","year":"2002","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000071460","article-title":"Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan","volume":"46","author":"F Suzuki","year":"2003","journal-title":"Intervirology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0168-8278(01)00246-X","article-title":"Hepatitis B viral genotypes and lamivudine resistance","volume":"36","author":"J Kao","year":"2002","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0168-8278(02)00410-5","article-title":"The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment","volume":"38","author":"N Akuta","year":"2003","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, LI C, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1","volume":"342","journal-title":"The New England Journal of Medicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2893.2005.00613.x","article-title":"Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance","volume":"12","author":"D Moskovitz","year":"2005","journal-title":"J Viral Hepat"},{"key":"ref32","first-page":"4178","article-title":"Characterization of hepatitis B virus genotypes\/subgenotypes in 1,301 patients with chronic hepatitis B in North China","volume":"124","author":"X Li","year":"2011","journal-title":"Chin Med J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1499-3872(12)60144-1","article-title":"Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment","volume":"11","author":"F Wu","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref34","first-page":"687","article-title":"Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis","volume":"36","author":"CL Lai","year":"2003"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/apc.2009.0322","article-title":"Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy","volume":"24","author":"P Wongprasit","year":"2010","journal-title":"AIDS Pat Care STDS"},{"key":"ref36","first-page":"159","article-title":"Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays","volume":"50","author":"B Moerman","year":"2004","journal-title":"Clin Lab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1309\/K5EM795VNGGFGBXX","article-title":"The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays","volume":"125","author":"S La\u2019ulu","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jmv.23183","article-title":"Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen","volume":"84","author":"Q Ma","year":"2012","journal-title":"J Med Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1155\/2012\/936259","article-title":"Reassessing the role of lamivudine in chronic hepatitis B infection: a four-year cohort analysis","volume":"26","author":"T Shaikh","year":"2012","journal-title":"Can J Gastroenterol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:49:46Z","timestamp":1589032186000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059346"}},"subtitle":[],"editor":[{"given":"Julian W.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,18]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059346","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,18]]}}}